Zacks Investment Research on MSN
Owlet vs. Masimo: Which medical monitoring stock is the better buy?
Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...
Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...
Irvine, California-based Masimo, makers of a suite of non-invasive patient monitoring devices and sensors, has expanded the capabilities of its connected platform to allow physicians to view more data ...
Masimo Corp. has urged a California federal judge to reject Apple’s bid to erase a US$634 million patent-infringement verdict ...
Masimo Corp. urged a California federal judge to reject Apple Inc.’s bid to erase a $634 million patent-infringement verdict over Apple Watch heart-rate alerts, arguing trial evidence supported the ...
Masimo’s Rainbow Acoustic Monitoring sensor, RAS-125 Acoustic Respiration Cloth Sensor, was granted FDA 510(k) clearance for monitoring pediatric patients. Previously, clinicians could only use the ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in Nashville, Tennessee, is piloting the use of ...
Zacks Investment Research on MSN
Here's why you should retain Masimo stock in your portfolio now
Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for innovative technology and research and development (R&D) efforts. The optimism, ...
Files Revised Definitive Proxy Materials and Mails Letter to Stockholders Urges Stockholders to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy ...
Why Masimo Is On Investors’ Radar Today Masimo (MASI) has drawn fresh attention after recent share price moves, with the stock last closing at $137.33. That price sits against a mixed performance ...
Masimo (Nasdaq:MASI) has opposed an attempt by Apple to overturn the recent patent infringement ruling ordering it to pay $634 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results